SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-015210
Filing Date
2024-05-08
Accepted
2024-05-08 07:54:15
Documents
16
Period of Report
2024-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zvra20240403_8k.htm   iXBRL 8-K 33272
2 EXHIBIT 99.1 ex_669682.htm EX-99.1 154954
7 zvralogo.jpg GRAPHIC 6458
  Complete submission text file 0001437749-24-015210.txt   347533

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240508.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20240508_def.xml EX-101.DEF 11424
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240508_lab.xml EX-101.LAB 15310
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240508_pre.xml EX-101.PRE 11584
19 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240403_8k_htm.xml XML 2837
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 24924288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)